Merck Kgaa
(MRK.D.DX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 3,830,000 | 3,724,000 | 3,805,000 | 3,665,000 | 3,463,600 |
| Cost of Goods | 1,328,000 | 1,251,000 | 1,315,000 | 1,307,000 | 1,149,200 |
| Gross Profit | 2,502,000 | 2,473,000 | 2,490,000 | 2,358,000 | 2,314,400 |
| Operating Expenses | 2,280,000 | 1,797,000 | 1,939,000 | 1,509,000 | 1,692,600 |
| Operating Income | 222,000 | 676,000 | 551,000 | 849,000 | 621,800 |
| Other Income | 113,000 | -67,000 | -122,000 | -69,000 | -457,600 |
| Pre-tax Income | 335,000 | 609,000 | 429,000 | 780,000 | 164,200 |
| Income Tax | 70,000 | 149,000 | 115,000 | 187,000 | 42,400 |
| Net Income Continuous | 265,000 | 460,000 | 314,000 | 593,000 | 121,800 |
| Minority Interests | 4,000 | -4,000 | -2,000 | -2,000 | -1,700 |
| Net Income | $269,000 | $457,000 | $312,000 | $591,000 | $125,700 |
| EPS Basic Total Ops | 0.62 | 1.05 | 0.72 | 1.36 | 0.29 |
| EPS Basic Continuous Ops | 0.62 | 1.05 | 0.72 | 1.36 | 0.28 |
| EPS Diluted Total Ops | 0.62 | 1.05 | 0.72 | 1.36 | 0.29 |
| EPS Diluted Continuous Ops | 0.62 | 1.05 | 0.72 | 1.36 | 0.28 |
| EBITDA(a) | $968,000 | $1,110,000 | $1,070,000 | $1,282,000 | $795,300 |